Estradiol Benzoate | Hormone Therapy Intermediate | GMP/USP-Compliant?
■■■■■■■■■■■■■■■■■■■■

?Product Overview?
Estradiol Benzoate is a high-purity steroid intermediate widely used in synthesizing estrogen-based pharmaceuticals, including hormone replacement therapies (HRT) and oncology formulations?12. It serves as a critical precursor for APIs in contraceptive drugs, cancer treatments, and veterinary hormone preparations?35.

?Key Advantages?
? ?>99% HPLC/GC-MS Verified?: Rigorous purity testing ensures batch-to-batch consistency?34.
? ?Stability-Optimized?: 24-month shelf life under controlled storage (15-25°C, dark)?45.
? ?Regulatory Compliance?: Manufactured under GMP and USP/EP pharmacopeia standards?23.

?Applications?
? ?Hormone Replacement Therapies?: Menopause management and osteoporosis prevention?15.
? ?Oncology Drug Synthesis?: Estrogen receptor-positive breast cancer treatments?26.
? ?Veterinary Pharmaceuticals?: Livestock fertility regulation and companion animal therapies?56.

?Quality Certifications?
■ ?ICH Q7 & ISO 9001?: Full documentation for traceability and regulatory audits?34.
■ ?Residual Solvent Control?: Meets USP <467> limits for methanol and ethyl acetate?24.

?Market Trends?
The global hormone therapy market is projected to grow at ?6.8% CAGR through 2030?, driven by rising demand for oncology and geriatric care solutions?56. Estradiol-based APIs account for ?18% of the estrogen therapeutics segment?, with contraceptive formulations showing 12% annual growth?12.

■■■■■■■■■■■■■■■■■■■■
?Optimized Keywords?:

• ?Hormone Replacement API Precursor?
• ?Oncology Formulation Intermediate?
• ?USP-Compliant Estradiol Derivative?
• ?High-Purity Steroid Synthesis?
• ?Veterinary Hormone Manufacturing?

?High-Value Search Terms?:

• GMP-Certified Estrogen Intermediate

• Breast Cancer Therapy Precursor

• Stability-Validated Hormone API

• Contraceptive Drug Synthesis

• USP/EP Pharmaceutical Grade